Dendritic cell vaccine treatment is a unique form of immunotherapy that has become more relevant among cancer patients. Dendritic cells are rare leukocytes, a type of cell that plays a role in signaling the body’s immune response. Dendritic cells specifically are unique in their ability to present antigens to T cells. By activating T cells, dendritic cells help to promote antitumor responses. These immune cells can help prevent the onset of cancer by suppressing the growth rate of tumor cells.

Dendritic cell therapy works by isolating dendritic cells that have been loaded with tumor antigens and administering them as a cellular vaccine. In studies, dendritic cell cancer treatment has been found to provide therapeutic and protective antitumor immunities and Clinical trials for cancer patients with melanoma and non-Hodgkin’s lymphoma show promising anti-tumor results.

Dendritic Cell therapy can be injected intravenously, intramuscularly, intradermally, or directly into the tumor. Intervals for injection frequency range from days to months. Consult with your doctor to determine the best mode of administration, dosage, and frequency of cancer immunotherapy based on your personal health needs.